New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma.

To further understand our findings, we carried out a univariate analysis ( Table 2 ) of possible confounding factors (gender, age, race, tumor size, nodal involvement, perineural invasion, lymphovascular invasion, and long-standing diabetes), which revealed NOD as trending towards significance for both OS (P=0.05) and PFS (P=0.06).

also in 515 other papers